Olaris CEO Elected to Personalized Medicine Coalition Board of Directors
Dr. Elizabeth O’Day will lead personalized medicine investment and adoption efforts globally during three-year term WALTHAM, Mass., June 9, 2020 …
Press Releases
Creative Enzymes Releases High-quality Enzyme Expression and Purification Service
Creative Enzymes, a professional enzymes provider located in New York, USA, always hammers at researches and trials in order to …
MOBILion Systems Unveils Novel Ion Mobility Product at Virtual ASMS Conference 2020
Chadds Fords, PA, June 5 2020: MOBILion Systems, Inc. is showcasing its first ion mobility separations product to the biopharma …
Bruker Introduces Breakthrough MALDI-2 Source on timsTOF fleX, and Further Innovations in CCS-Enabled 4D Proteomics on timsTOF
MALDI-2 Increases Small Molecule Sensitivity by One or Two Orders of Magnitude New prm-PASEF Workflow for Translational 4D Proteomics Large-Scale, …
Biorelate offers free access to AI-based drug discovery tool: Galactic
5 June 2020: Biorelate, a UK-based AI start up, is offering all researchers free use of Galactic, its cloud-based web …
Greenphire Launches, EnvisiX, A New Clinical Trial Budget Build and Negotiation Solution
Today, Greenphire, the global leader in financial lifecycle management for clinical trials, announced the launch of a new budget development solution, EnvisiX, …
AI drug discovery company Syntekabio identified respiratory disease drug as a potential COVID19 therapeutics
Respiratory disease drug identified as potential COVID-19 therapeutics AI-driven drug repositioning allowed a rapid search for COVID-19 drug candidates Exploring …
Update: Registration for Creative Biolabs’ Webinar About ConvertibleCAR-T Is Now Opened
Recognized as the leading custom service provider with extensive experience in TCR and CAR-T&NK cell immune therapy development, Creative Biolabs …
Creative Biolabs Unveils All-inclusive Antiviral Drug Discovery Services for SARS-CoV-2
To facilitate global research about drugs or vaccines for COVID-19, Creative Biolabs has launched a series of antiviral drug discovery …
Greenphire Enhances ClinCard to Further Support Remote Clinical Trials
As the COVID-19 pandemic continues to limit movement all over the world, clinical trials have had to adapt by leveraging …
Exyte and Univercells Technologies Combine Аorces for Rapid Deployment of Vaccine Production Plants in the Wake of the COVID-19 Pandemic
Exyte offers the new ExyCellR modular technology for fast-track construction of biologicals production facilities compliant with the current good manufacturing …
Pulmotect receives FDA approval to commence two Phase-2 trials targeting COVID-19
Houston, TX (May 2020) – Pulmotect, Inc., a clinical-stage biotechnology company, has received approval from the U.S. Food & Drug …
